PharmGKB — TERI Ellen KLEIN (STANFORD UNIVERSITY)
Project Summary/Abstract Pharmacogenomics is the study of how genetic variation influences drug response phenotypes and is a pillar of precision medicine — choosing the right drug for the right patien
| Project title | PharmGKB |
|---|---|
| Project number | 2U24HG010615-04 |
| PI name | TERI Ellen KLEIN |
| Institution | STANFORD UNIVERSITY |
| Funding mechanism | U24 |
| Agency | NHGRI |
| Award amount | $1.50M |
| Fiscal year | 2023 |
| Project start | 2020-04-03T00:00:00 |
| Project end | 2025-12-31T00:00:00 |
| Abstract | Project Summary/Abstract Pharmacogenomics is the study of how genetic variation influences drug response phenotypes and is a pillar of precision medicine — choosing the right drug for the right patien |
| Key terms | <Academia><Adverse Experience><Adverse effects><Adverse event><Area><Basic Research><Basic Science>< |
$799/mo
Try GrantRadar →